Navigation Links
Fuisz Pharma LLC Announces Patent Filing for Novel System and Method to Obtain Blood for Diagnostic Analysis Using a Lancet or Needle Puncture
Date:1/14/2014

MIAMI, Jan. 14, 2014 /PRNewswire/ -- Fuisz Pharma announced that it has filed a new patent application with the United States Patent & Trademark Office for a state of the art system, method and kit to obtain blood samples from a finger stick. The blood obtained is greater in volume and includes a system of management of capillary tubes and of obtaining refreshed capillary field blood that more closely approximates the diagnostic gold standard, venous blood, than traditional finger stick draws do.

Joseph Fuisz, managing member for Fuisz Pharma LLC, commented: "This is an exciting breakthrough in an area that had been static for far too long.  It enables a substantial increase in harvested blood draw from a single stick.  We feel this invention will be useful if the finger stick becomes commonplace in broad-based blood analytics."

Richard Fuisz M.D. added: "I am old enough and experienced enough in life to know that horses precede carts. If in the future blood diagnostics is based broadly in many parameters from a finger stick, then a better way needed to be invented to increase the yield of blood volume and improve the blood quality from a finger stick. We feel we have not just the better way but the essential way to accomplish the task."

Fuisz Pharma LLC is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, and have extensive experience working with big and specialty pharma.  Fuisz Pharma is also active in diagnostic systems.  Fuisz Pharma has its headquarters in Miami. www.fuisz.com.


'/>"/>
SOURCE Fuisz Pharma LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
2. Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown Universitys 1789 Society.
3. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
4. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
5. Upsher-Smith Honors 42 Pharmacists Nationwide For Excellence In Innovation
6. ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Big pharmas need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive
11. Mezzion Pharma Announces Collaboration With New England Research Institutes To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Februar 2017 ITL Limited, ( ASX: ... ist erfreut, für das zum 31. Dezember 2016 ... exzellente Ergebnisse vorlegen zu können. Eine vollständige Präsentation ... finden Sie hier . ... 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... Feb. 23, 2017  This report analyzes the worldwide ... following Products: Intermediates, Analytical, and Others. ... include Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive ... Europe , and Rest of World. ... 2015 through 2022. Also, a six-year historic analysis is ...
(Date:2/24/2017)... STOCKHOLM , Feb 24, 2017 ... Nomination Committee,s proposal for a new Board of Directors ... Meeting. The 2016-2017 Nomination Committee comprises representatives of the ... third quarter of 2016 who have accepted a seat ... Board. The composition of the 2016-2017 Nomination Committee was ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current ... will soon begin franchising throughout the U.S. starting this spring. Current Meditation focuses ... practice of meditation mainstream. Current Meditation will be the first meditation concept in ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Top ... Smiling Patriot program today with a new Indiegogo campaign . Individuals ... to homeless veterans in the Los Angeles area, either as a participating patient or ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it ... healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s ... systems recently invested $51 million to purchase and renovate the 185,000 square-foot office ...
Breaking Medicine News(10 mins):